Literature DB >> 11812681

Ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than bupivacaine.

Manoj K Karmakar1, Cindy S T Aun, Eliza L Y Wong, April S Y Wong, Simon K C Chan, Chung K Yeung.   

Abstract

UNLABELLED: We compared the systemic absorption of ropivacaine and bupivacaine after caudal epidural administration in children. Twenty ASA physical status I or II children aged 1-7 yr undergoing elective hypospadias repair were randomized after the induction of general anesthesia to receive a single caudal epidural injection of 2 mg/kg of either ropivacaine 0.2% (R) or bupivacaine 0.2% (B) in a double-blinded fashion. Peripheral venous blood samples (1 mL) were obtained before and 1, 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, and 120 min after the caudal injection. The total R and B concentration was measured in plasma by using high-performance liquid chromatography. All blocks were successful, and there were no complications. The peak plasma concentration (mean +/- SD) (R = 0.67 +/- 0.16 and B = 0.73 +/- 0.23 microg/mL) and the area under the plasma concentration curve (R = 61.9 +/- 20.6 and B = 62.7 +/- 18.2 microg x mL(-1) x min(-1)) were comparable between the two study groups. The median (range) time to attain peak plasma concentration was significantly slower in children who received ropivacaine (R = 65 [10-120] min and B = 20 [15-50] min, P < 0.05). We conclude that ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than does bupivacaine. IMPLICATIONS: We compared the systemic absorption of ropivacaine (0.2%) and bupivacaine (0.2%) after caudal epidural injection of 2 mg/kg in children aged 1-7 yr. Our results show that ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than does bupivacaine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812681     DOI: 10.1097/00000539-200202000-00006

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.

Authors:  Jean-Xavier Mazoit
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 3.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Pharmacokinetics of local anaesthetics in infants and children.

Authors:  Jean-Xavier Mazoit; Bernard J Dalens
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Comparison of ropivacaine and bupivacaine with fentanyl for caudal epidural in pediatric surgery.

Authors:  Tarlika P Doctor; Divyang B Dalwadi; Lissa Abraham; Namrata Shah; Indu A Chadha; Bharat J Shah
Journal:  Anesth Essays Res       Date:  2013 May-Aug

6.  Prospective randomized controlled comparison of caudal bupivacaine and ropivacaine in pediatric patients.

Authors:  Ss Chipde; M Banjare; Kk Arora; M Saraswat
Journal:  Ann Med Health Sci Res       Date:  2014-07

7.  Clonidine as an Adjuvant to Caudal Epidural Ropivacaine for Lumbosacral Spine Surgeries.

Authors:  Saraswathi Nagappa; Sandhya Kalappa; Raghavendra Biligiri Sridhara
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

Review 8.  Update on the clinical utility and practical use of ropivacaine in Chinese patients.

Authors:  Man Li; Li Wan; Wei Mei; Yuke Tian
Journal:  Drug Des Devel Ther       Date:  2014-09-09       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.